Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · Real-Time Price · USD
43.76
+0.72 (1.67%)
At close: Nov 7, 2025, 4:00 PM EST
43.70
-0.06 (-0.14%)
After-hours: Nov 7, 2025, 6:59 PM EST
Phibro Animal Health Revenue
Phibro Animal Health had revenue of $363.89M in the quarter ending September 30, 2025, with 39.73% growth. This brings the company's revenue in the last twelve months to $1.40B, up 33.71% year-over-year. In the fiscal year ending June 30, 2025, Phibro Animal Health had annual revenue of $1.30B with 27.37% growth.
Revenue (ttm)
$1.40B
Revenue Growth
+33.71%
P/S Ratio
1.27
Revenue / Employee
$565,526
Employees
2,475
Market Cap
1.77B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 1.30B | 278.54M | 27.37% |
| Jun 30, 2024 | 1.02B | 39.79M | 4.07% |
| Jun 30, 2023 | 977.89M | 35.63M | 3.78% |
| Jun 30, 2022 | 942.26M | 108.91M | 13.07% |
| Jun 30, 2021 | 833.35M | 33.00M | 4.12% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
PAHC News
- 1 day ago - Phibro Animal Health Corporation (PAHC) Q1 2026 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Phibro Animal Health Corporation Reports First Quarter Results, Updates Financial Guidance - Business Wire
- 3 days ago - Phibro Animal Health Corporation Declares Quarterly Dividend - Business Wire
- 8 days ago - Phibro Animal Health Corporation Announces National Launch of Restoris™ Piezoelectric Dental Gel for Dogs - Business Wire
- 9 days ago - Phibro Animal Health Corporation to Host Webcast and Conference Call on First Quarter Results - Business Wire
- 4 weeks ago - Phibro Animal Health Corporation Announces Licensing Agreement with Lighthouse Pharmaceuticals, Inc. for Innovative Periodontal Health Asset for Dogs - Business Wire
- 2 months ago - Phibro Animal Health Corporation (PAHC) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript - Seeking Alpha
- 2 months ago - Phibro Animal Health Corporation to Participate at Morgan Stanley Annual Global Healthcare Conference - Business Wire